Evidence map›Paper›PMID 29064085›Full record

ReviewImmunology2018

The biology of natural killer cells during sepsis.

Yin Guo, Naeem K Patil, Liming Luan, Julia K Bohannon, Edward R Sherwood

Open access · bronzeAbstract readReview
In one paragraph

Review in Immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 123 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Bacteria and host: what does this mean for sepsis bottleneck?World journal of emergency medicine · 2025
    Review
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yin GuoDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-2420-4345
Naeem K PatilDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Liming LuanDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Julia K BohannonDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.
Edward R SherwoodDepartment of Anesthesiology, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID 0000-0002-9505-7178
Vanderbilt University Medical Center · US

Funding

Resistance of Beta 2 Microglobulin Null Mice to SepsisR01GM066885 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI SHERWOOD, EDWARD R · 2003 to 2016
$4.4M
Enhancing Resistance to Infection after Burn Injury with TLR AgonistsR01GM121711 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BOHANNON, JULIA K. · 2017 to 2021
$1.6M
NIGMS NIH HHS R01 GM066885NIGMS NIH HHS R01 GM121711
6 · The paper itself

Abstract

Natural killer (NK) cells are large granular lymphocytes largely recognized for their importance in tumour surveillance and the host response to viral infections. However, as the major innate lymphocyte population, NK cells also coordinate early responses to bacterial infections by amplifying the antimicrobial functions of myeloid cells, especially macrophages, by production of interferon-γ (IFN-γ). Alternatively, excessive NK cell activation and IFN-γ production can amplify the systemic inflammatory response during sepsis resulting in increased physiological dysfunction and organ injury. Our understanding of NK cell biology during bacterial infections and sepsis is mostly derived from studies performed in mice. Human studies have demonstrated a correlation between altered NK cell functions and outcomes during sepsis. However, mechanistic understanding of NK cell function during human sepsis is limited. In this review, we will review the current understanding of NK cell biology during sepsis and discuss the challenges associated with modulating NK cell function during sepsis for therapeutic benefit.

Indexed as

Lymphocyte ActivationAnimalsBacterial InfectionsHumansInterferon-gammaKiller Cells, NaturalMiceSepsisIFNG protein, humanInterferon-gammainflammationinnate lymphoid cellsnatural killer cellsepsis

Identifiers

PMID29064085
PMCPMC5765373
OpenAlexW2765809068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.